|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
38
|
|
pubmed:dateCreated |
2001-5-29
|
|
pubmed:abstractText |
In this report, risk factors of intrahepatic recurrence of a large solitary hepatocellular carcinoma after combination therapy with transcatheter arterial embolization followed by percutaneous ethanol injection were studied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0172-6390
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
480-5
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11379338-Adult,
pubmed-meshheading:11379338-Aged,
pubmed-meshheading:11379338-Aged, 80 and over,
pubmed-meshheading:11379338-Carcinoma, Hepatocellular,
pubmed-meshheading:11379338-Embolization, Therapeutic,
pubmed-meshheading:11379338-Ethanol,
pubmed-meshheading:11379338-Female,
pubmed-meshheading:11379338-Humans,
pubmed-meshheading:11379338-Injections, Intralesional,
pubmed-meshheading:11379338-Liver Neoplasms,
pubmed-meshheading:11379338-Male,
pubmed-meshheading:11379338-Middle Aged,
pubmed-meshheading:11379338-Neoplasm Recurrence, Local,
pubmed-meshheading:11379338-Risk Factors
|
|
pubmed:articleTitle |
Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI.
|
|
pubmed:affiliation |
Third Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama, Japan.
|
|
pubmed:publicationType |
Journal Article
|
